Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Lancet HIV. 2020 Jun;7(6):e422–e433. doi: 10.1016/S2352-3018(20)30103-X

Table 2.

Prevalence ratios (PR) and 95% confidence intervals (CI) for intervention coverage in six communities participating in the end-of-study survey for the Ya Tsie study.

Intervention vs. standard-of-care
PR (95% CI)a,b
Endpoint Baseline Study end
HIV-tested (prior 12 months) or previously diagnosed HIV-positive (among all participants) 0·82
(0·69, 0·98)
1·29
(1·17, 1·43)
Previously diagnosed HIV-positive (among all HIV-positive participants) 0·97
(0·94, 1·00)
1·08
(1·02, 1·14)
Current receipt of ART (among all HIV-positive participants) 0·94
(0·93, 0·95)
1·12
(1·07, 1·17)
Virally suppressed on ART (among all HIV-positive participants) 0·94
(0·93, 0·94)
1·13
(1·09, 1·17)
Self-reported circumcised (among HIV-negative men aged 16–49 years) 0·92
(0·86, 0·99)
1·26
(1·17, 1·35)
a

All models adjusted for matched pair and matched pair by time interaction.

b

95% CIs were computed using robust variance accounting for clustering at the community level.